CWW promotes relationships and networks among partners and serves as a repository of information on STH control. In addition, we remain committed to deepening our understanding of STH to accelerate effective treatment and prevention. Through our technical and scientific collaboration work, we:
- Collaborate on and contribute to peer-reviewed publications on STH policy and scientific issues of importance to the field
- Help to identify operational research questions
- Partner with WHO to facilitate rapid adoption of research findings
- Encourage assessment of the impact of STH interventions in field settings
STH Advisory Committee
Our technical and scientific collaboration work is guided by the STH Advisory Committee, an independent group of experts with a wealth of experience in parasitology, epidemiology, child health, education, and international public health. CWW serves as the secretariat for the STH Advisory Committee, which in turn advises CWW, the STH Coalition, GSK, Johnson & Johnson, and others on strategic and technical components of STH treatment and prevention, including safe, rational, and effective administration of the donated albendazole and Vermox™ (mebendazole). The STH Advisory Committee makes recommendations to address technical and scientific challenges and monitors progress in STH operational research and in monitoring and evaluation of STH programs.
The STH Advisory Committee also provides STH-related technical and scientific advice to the WHO Strategic and Technical Advisory Group’s (STAG) working group on monitoring and evaluation, and advises the NTD Support Center on operational research priorities for STH control as part of its “Filling the Gaps” research grant from the Bill & Melinda Gates Foundation.